Snowball logo
logo
3260_logo

Sk Biopharmaceuticals Co Ltd

326030 KO
87,600.00-600.00  (0.68%)
💡 Click on a row in the table to make it appear on the graph
📊 Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
418,644.5246,179.1354,891.6547,596.3706,741790,249.7
COGS
22,33637,768.134,082.543,100.942,901.446,734.8
Gross Profit
396,308.5208,411320,809.1504,495.4663,839.5743,514.9
Operating Expenses & Income
Operating Income
94,958.2(131,078)(37,522.2)96,339.7203,938.5268,034.8
Total Operating Expenses
323,686.3377,257.1392,413.8451,256.6502,802.5522,214.9
R&D Expenses
114,526.3122,816.7137,126.1161,270.3174,344.1179,933.3
Selling General & Admin Expenses
89,801.3112,321.5101,868.4114,786.3146,290.2154,032.9
Earnings from Continuing Operations
Interest Expense
(947)(3,716.5)(8,279.6)(10,682.5)(7,690.7)(6,454)
Interest Income
2,342.96,754.89,317.510,146.27,084.67,073.3
Income Tax Expense
6,430.9(3,038)----
Net Income
Net Income
64,845.6(139,430.9)(32,882.8)240,738266,950.5348,807.9
Supplemental
EBIT
94,958.2(131,078)----
EBITDA
83,865.4(125,768.6)----
In millions of KRW, except % and values per 1 share